129 related articles for article (PubMed ID: 37010353)
21. Quantification of vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid in urine using a dilute-and-shoot and ultra-high pressure liquid chromatography tandem mass spectrometry method.
Grouzmann E; Centeno C; Eugster PJ
Clin Chem Lab Med; 2018 Aug; 56(9):1533-1541. PubMed ID: 29708876
[TBL] [Abstract][Full Text] [Related]
22. Determination of homovanillic acid and vanillylmandelic acid in neuroblastoma screening by stable isotope dilution GC-MS.
Fauler G; Leis HJ; Huber E; Schellauf C; Kerbl R; Urban C; Gleispach H
J Mass Spectrom; 1997 May; 32(5):507-14. PubMed ID: 9180052
[TBL] [Abstract][Full Text] [Related]
23. HPLC-mass spectrometry method for quantitative detection of neuroendocrine tumor markers: vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid.
Lionetto L; Lostia AM; Stigliano A; Cardelli P; Simmaco M
Clin Chim Acta; 2008 Dec; 398(1-2):53-6. PubMed ID: 18760269
[TBL] [Abstract][Full Text] [Related]
24. Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma.
Candito M; Soler C; Deville A; Bekri S; Chambon P; Thyss A
Med Pediatr Oncol; 1996 Jan; 26(1):57-60. PubMed ID: 7494513
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the diurnal variations in urinary homovanillic and vanillylmandelic acid excretion for the diagnosis and follow-up of patients with neuroblastoma.
Tuchman M; Robison LL; Maynard RC; Ramnaraine ML; Krivit W
Clin Biochem; 1985 Jun; 18(3):176-9. PubMed ID: 4039636
[TBL] [Abstract][Full Text] [Related]
26. Biochemical testing for neuroblastoma using plasma free 3-O-methyldopa, 3-methoxytyramine, and normetanephrine.
Peitzsch M; Butch ER; Lovorn E; Mangelis A; Furman WL; Santana VM; Hero B; Berthold F; Shulkin BL; Huebner A; Eisenhofer G
Pediatr Blood Cancer; 2020 Feb; 67(2):e28081. PubMed ID: 31724812
[TBL] [Abstract][Full Text] [Related]
27. Olive ingestion causing a false suspicion of relapsed neuroblastoma: A case of "oliveblastoma?".
Flynn N; LeFebvre A; Messahel B; Hogg SL
Pediatr Blood Cancer; 2018 Oct; 65(10):e27248. PubMed ID: 29923309
[TBL] [Abstract][Full Text] [Related]
28. Determination of serum catecholamine metabolites in neuroblastoma by high performance liquid chromatography with electrochemical detection.
Tang QM; Xu XR; Shi YQ; Jin BX
Biomed Chromatogr; 1986 Feb; 1(1):7-11. PubMed ID: 3506818
[TBL] [Abstract][Full Text] [Related]
29. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
[TBL] [Abstract][Full Text] [Related]
30. The effect of disulfiram on the urinary excretion of catecholamine metabolites in alcoholic males.
Robins AH; Barron JL
S Afr Med J; 1983 Jan; 63(2):41-2. PubMed ID: 6849160
[TBL] [Abstract][Full Text] [Related]
31. Urine catecholamine levels as diagnostic markers for neuroblastoma in a defined population: implications for ophthalmic practice.
Smith SJ; Diehl NN; Smith BD; Mohney BG
Eye (Lond); 2010 Dec; 24(12):1792-6. PubMed ID: 20865029
[TBL] [Abstract][Full Text] [Related]
32. Effect of diet on urinary excretion of VMA, HVA, metanephrine, and total free catecholamine in normal preschool children.
Weetman RM; Rider PS; Oei TO; Hempel JS; Baehner RL
J Pediatr; 1976 Jan; 88(1):46-50. PubMed ID: 1245941
[TBL] [Abstract][Full Text] [Related]
33. Increased urinary HVA levels in neuroblastoma screens related to diet, not tumor.
Numata K; Kusui H; Kawakatsu H; Kizaki Z; Sawada T
Pediatr Hematol Oncol; 1997; 14(6):569-76. PubMed ID: 9383810
[TBL] [Abstract][Full Text] [Related]
34. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
Tuchman M; Ramnaraine ML; Woods WG; Krivit W
Pediatrics; 1987 Feb; 79(2):203-5. PubMed ID: 3808793
[TBL] [Abstract][Full Text] [Related]
35. Elevated catecholamine metabolites in patients with Costello syndrome.
Gripp KW; Kawame H; Viskochil DH; Nicholson L
Am J Med Genet A; 2004 Jul; 128A(1):48-51. PubMed ID: 15211656
[TBL] [Abstract][Full Text] [Related]
36. Mass screening for neuroblastoma in Miyagi Prefecture.
Itano M; Morita S; Fujie H; Ohashi Y; Minegishi N; Minegishi M; Yamaguchi Y; Sato T; Tsuchiya S; Konno T
Tohoku J Exp Med; 1992 Oct; 168(2):137-9. PubMed ID: 1306297
[TBL] [Abstract][Full Text] [Related]
37. Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.
Sato Y; Hanai J; Takasugi N; Takeda T
Tohoku J Exp Med; 1986 Oct; 150(2):169-74. PubMed ID: 3810642
[TBL] [Abstract][Full Text] [Related]
38. Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: report from the Italian Cooperative Group for Neuroblastoma.
Barco S; Gennai I; Reggiardo G; Galleni B; Barbagallo L; Maffia A; Viscardi E; De Leonardis F; Cecinati V; Sorrentino S; Garaventa A; Conte M; Cangemi G
Clin Biochem; 2014 Jun; 47(9):848-52. PubMed ID: 24769278
[TBL] [Abstract][Full Text] [Related]
39. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
[TBL] [Abstract][Full Text] [Related]
40. Catecholamine metabolism in neuroblastoma.
LaBrosse EH; Comoy E; Bohuon C; Zucker JM; Schweisguth O
J Natl Cancer Inst; 1976 Sep; 57(3):633-8. PubMed ID: 10450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
